Amgen Inc. buy Royal Bank of Canada
Start price
07.02.24
/
50%
€281.00
Target price
07.02.25
€305.58
Performance (%)
11.46%
Price
09:30
€309.05
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 11.46%. A total of €4.16 was paid as dividends for this prediction. This prediction currently runs until 07.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 0.879% | 0.879% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $303.00 to $329.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat